Cary Street Partners Investment Advisory LLC Vertex Pharmaceuticals Inc Transaction History
Cary Street Partners Investment Advisory LLC
- $152 Billion
- Q4 2024
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 225 shares of VRTX stock, worth $108,954. This represents 0.06% of its overall portfolio holdings.
Number of Shares
225
Previous 24,220
99.07%
Holding current value
$108,954
Previous $11.3 Million
704.39%
% of portfolio
0.06%
Previous 0.43%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,753Shares Held
227MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.7 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.3 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.8 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.05 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $124B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...